We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.75B
AUM Growth
+$206M
Cap. Flow
+$146M
Cap. Flow %
8.36%
Top 10 Hldgs %
14.9%
Holding
338
New
39
Increased
82
Reduced
149
Closed
38

Top Sells

Rank Stock Value
1
CYBX
CYBERONICS INC
CYBX
+$18.5M
2
FIVE icon
Five Below
FIVE
+$13.2M
3
FARO
Faro Technologies
FARO
+$11.4M
4
AKRX
Akorn Inc
AKRX
+$10.2M
5
MATX icon
Matsons
MATX
+$8.83M

Sector Composition

Rank Sector Weight
1 Industrials 18.82%
2 Healthcare 17.25%
3 Technology 17.24%
4 Consumer Discretionary 13.08%
5 Communication Services 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGO icon
301
AngioDynamics
ANGO
$649M
-152,667
Closed -$2.01M
BBW icon
302
Build-A-Bear
BBW
$462M
-119,193
Closed -$2.25M
CYH icon
303
Community Health Systems
CYH
$423M
-71,112
Closed -$2.51M
ENPH icon
304
Enphase Energy
ENPH
$5.53B
-205,887
Closed -$762K
EVRI
305
DELISTED
Everi Holdings
EVRI
-227,632
Closed -$1.17M
FARO
306
DELISTED
Faro Technologies
FARO
-325,685
Closed -$11.4M
GRMN
307
Garmin
GRMN
$60B
-47,533
Closed -$1.71M
HBIO icon
308
Harvard Bioscience
HBIO
$29.2M
-31,410
Closed -$1.19M
ITW icon
309
Illinois Tool Works
ITW
$84.5B
-3,954
Closed -$325K
JCI icon
310
Johnson Controls International
JCI
$92.2B
-12,320
Closed -$534K
MDGL icon
311
Madrigal Pharmaceuticals
MDGL
$11.8B
-843
Closed -$51K
QDEL icon
312
QuidelOrtho
QDEL
$838M
-32,838
Closed -$620K
RBA icon
313
RB Global
RBA
$17.5B
-64,140
Closed -$1.66M
SHOE
314
Shoe Station Group
SHOE
$428M
-168,096
Closed -$2M
SLB icon
315
SLB Ltd
SLB
$75B
-3,400
Closed -$234K
EMWP
316
DELISTED
Eros Media World PLC
EMWP
-2,796
Closed -$1.52M
GEN
317
DELISTED
Genesis Healthcare, Inc.
GEN
-231,088
Closed -$1.42M
AXAS
318
DELISTED
Abraxas Petroleum Corp
AXAS
-20,184
Closed -$517K
LBY
319
DELISTED
Libbey, Inc.
LBY
-57,920
Closed -$1.89M
AKRX
320
DELISTED
Akorn Inc
AKRX
-358,323
Closed -$10.2M
BID
321
DELISTED
Sotheby's
BID
-116,972
Closed -$3.74M
HZNP
322
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-427,163
Closed -$8.47M
SN
323
DELISTED
Sanchez Energy Corporation
SN
-627,711
Closed -$3.86M
CGI
324
DELISTED
Celadon Group Inc
CGI
-96,968
Closed -$1.55M
HSNI
325
DELISTED
HSN, Inc.
HSNI
-48,648
Closed -$2.79M

Similar funds

Rice Hall James & Associates's Q4 2015 Portfolio in Review

As of Q4 2015, Rice Hall James & Associates held 338 positions worth $1.75B, up 13% from $1.54B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Rice Hall James & Associates deployed $146M of net new capital in Q4 2015, opening 39 new positions and adding to 82 existing holdings. Its largest new stake was LivaNova: 300,399 shares worth $17.8M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Five Below, an estimated $13.2M trimmed.

  • Rice Hall James & Associates's largest Q4 2015 buy was LivaNova: 300,399 shares worth $17.8M.
  • Rice Hall James & Associates added most to Criteo S.A. Ordinary Shares in Q4 2015, an estimated $10.2M increase.
  • Rice Hall James & Associates's biggest Q4 2015 reduction was Five Below, cutting an estimated $13.2M.
  • Rice Hall James & Associates fully exited CYBERONICS INC in Q4 2015, selling an estimated $18.5M.
  • Rice Hall James & Associates's ten largest holdings make up 15% of its $1.75B portfolio in Q4 2015.
  • Rice Hall James & Associates opened 39 new positions and closed 38 in Q4 2015.
  • Rice Hall James & Associates's portfolio value rose 13% quarter-over-quarter to $1.75B.

Based on Rice Hall James & Associates's 13F filing for Q4 2015, filed 28 Jan 2016.